Positive and Healthy Living peer-led programme (PHL-PLP)

Effectiveness and feasibility of positive and healthy living peer-led programme (PHL-PLP) on neurocognitive outcomes and psychosocial determinants of HIV positive children and adolescents

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202606602363676

Enrollment

Registered

2026-06-17

Start date

2026-06-08

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS Mental and Behavioural Disorders

Interventions

positive support programme

treatment as usual

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Participants will be adolescents and young people meeting the following criteria: ? Know their HIV status - HIV status has been disclosed to them ? Full written informed assent from minors aged 10-17 years including written informed consent by caregiver ? Written informed consent from mature adolescents aged 18 years and emancipated minors aged 15-17 years, to participate in the study. ? Knowledge of Setswana and/or English. ? Able to attend 8 sessions once every 2 weeks

Exclusion criteria

Exclusion criteria: ? Diminished mental capacity that makes them not able to comprehend and communicate. ? Severe psychopathology such as HIV related psychosis, pervasive childhood disorders, severe depression, or suicidal ideation

Design outcomes

Primary

Measure	Time frame
(1)Reach – how many of the approached ALHIV are willing to participate in the study. (2)Adoption and retention - the number of enrolled participants who attend =50% of sessions and undergo the final assessment at 6 months; (3)Acceptability of the co-adapted intervention to determine how well the target population will receive the adapted intervention, the extent to which the intervention components meet the needs of the target population and the setting and (4)Implementation - assess fidelity to the various elements of the intervention’s protocol, including consistency and adherence of the intervention delivery as intended as well as the adolescents’ use of the intervention strategies during the study.	—

Measure

Time frame

(1)Reach – how many of the approached ALHIV are willing to participate in the study. (2)Adoption and retention - the number of enrolled participants who attend =50% of sessions and undergo the final assessment at 6 months; (3)Acceptability of the co-adapted intervention to determine how well the target population will receive the adapted intervention, the extent to which the intervention components meet the needs of the target population and the setting and (4)Implementation - assess fidelity to the various elements of the intervention’s protocol, including consistency and adherence of the intervention delivery as intended as well as the adolescents’ use of the intervention strategies during the study.

—

Secondary

Measure	Time frame
HIV-related: viral suppression, adherence (Morisky medication adherence tool) and stigma (Internalized AIDS related Stigma Scale) Neurocognitive and psychosocial functioning: The neurocognitive – (KABC-II), the Depression (PHQ-9), self-esteem (Rosenberg self-esteem), social functioning using HEADSS	—

Countries

Botswana

Contacts

Public ContactOtsetswe Musindo

Principal Clinical Psychologist II

otisbina@outlook.com+26774165432

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026